Weighted Average Number of Shares Outstanding, Diluted of CITIUS ONCOLOGY, INC. from 30 Jun 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CITIUS ONCOLOGY, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2022 to 31 Dec 2025.
  • CITIUS ONCOLOGY, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 87,462,385, a 22% increase year-over-year.
  • CITIUS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 73,267,969, a 7.7% increase from 2024.
  • CITIUS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 68,053,607, a 931% increase from 2023.
  • CITIUS ONCOLOGY, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6,600,000, a 392% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 87,462,385 +15,909,983 +22% 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 73,267,969 +5,214,362 +7.7% 01 Jul 2025 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 71,552,402 +4,052,402 +6% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 71,552,402 +4,052,402 +6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 71,552,402 +4,052,402 +6% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2026 2026 Q1
Q3 2024 68,053,607 +61,453,607 +931% 01 Jul 2024 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 67,500,000 +60,900,000 +923% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q3
Q1 2024 67,500,000 +60,900,000 +923% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q2
Q4 2023 67,500,000 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
Q3 2023 6,600,000 +5,100,000 +340% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 6,600,000 +5,100,000 +340% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 6,600,000 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q3 2022 1,500,000 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 1,500,000 01 Apr 2022 30 Jun 2022 10-Q 16 Aug 2023 2023 Q2

CITIUS ONCOLOGY, INC. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 73,267,969 +5,214,362 +7.7% 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2024 68,053,607 +61,453,607 +931% 01 Oct 2023 30 Sep 2024 10-K 23 Dec 2025 2025 FY
2023 6,600,000 +5,258,242 +392% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 1,341,758 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.